United States: An Examination "Off-Ramp" For Motions To Amend Still Raises Hopes And Questions

During the first three years of implementing the America Invents Act (AIA), Patent Trial and Appeal Board (PTAB) decision-making created a perception that a patent owner's ability to amend claims during a post-grant proceeding was limited, at best. In 2015, legislative activity began to address this perceived problem with draft amendments to the patent statute.

While specific proposals varied, the concept of one approach was that a patent owner seeking to amend claims during a PTAB trial, could prosecute its proposed amendments like ordinary examination (or reexamination) in parallel with the underlying PTAB trial. This amendment examination process, termed an "off ramp" by some, has raised a number of policy and administrative issues. Many of these had solutions around which broad consensus might have been reached; for others, it was less clear. At the time, the legislative effort did not mature. Since then, however, conditions underlying the effort have not abated. In 2016, the en banc Federal Circuit heard argument in In re Aqua Prods. on whether the PTAB has been wrongly placing a burden on the patent owner regarding patentability of amended claims, underscoring potential problems with the current motion to amend practice. The possible outcomes in Aqua Products, either the status quo which motivated the earlier legislative activity, or a reversal potentially placing greater burdens on the PTAB, arguably make an alternative to the current motion to amend practice even more advantageous.


Congress provided in the AIA that a patentee may file a motion to amend the patent during an IPR or Post Grant Review (PGR), mandating that the Patent Office Director "prescribe regulations . . . setting forth standards and procedures for allowing the patent owner to move to amend the patent." 35 U.S.C. §§ 316 and 326. As interpreted by the Board, the regulations require that the patentee meet a burden to show patentability of the amended claims. See Idle Free Sys., Inc. v. Bergstrom, IPR 2012-00027, 2013 WL 5947697, at *4 (PTAB June 11, 2013); see also 37 C.F.R. § § 42.121 and 42.221; § 42.20. In practice, however, the particulars became an evolving set of requirements announced in decisions denying a motion to amend.

As a patent owner was generally allowed only one motion to amend, if that motion was denied for procedural or other reasons that the patent owner might have addressed, PTAB practice fostered a perception that patent owners could not obtain or maintain patent rights via motion to amend to which their inventions were entitled. At the same time, it was unclear if reexamination or reissue proceedings provided a meaningful alternative. PTAB panels often would stay these during a trial, delaying a patent owner's opportunity to pursue amended claims and potentially limiting the examining corps' ability to allow claims via an estoppel that would not have been present earlier and with which an examiner might not agree. See 37 C.F.R. § 42.73(d)(3). At least for a period, there also appeared to be disagreement within the Office about the availability of these procedures for claims involved in a trial. The upshot of Patent Office practice, as it evolved, often was that patent quality was not being improved where it might have been by allowing the examining corps to evaluate amendments in light of evidence developed via inter partes trial.

Patent-owning stakeholders and the bar got the attention of Congress in early 2015 and draft legislation began to emerge. One bill would have required granting a first motion to amend (see S.632 — 114th Congress (2015-2016) (the "STRONG PATENTS ACT of 2015"), §§ 102(b)–(c) and 103(b)–(c)) and other draft language discussed with staffers pursued a middle ground "off-ramp" solution.


For patent owners, the "off-ramp" proposals could provide a number of benefits. One is a change of the burden of persuasion for entitlement to amended claims. Normally, an inventor may obtain patent claims for his or her invention unless the Director makes a specific rejection or objection to a claim after examination. 35 U.S.C. § 101, 131–32. That is, the Patent Office has the burden of production of an initial prima facie case of unpatentability of a claim. See, e.g., In re Oetiker, 977 F.2d 1443, 1445 (Fed.Cir.1992). When the same claim is presented in a motion to amend during an IPR or PGR, the patent owner has a burden to convince the PTAB panel that the claim is patentable. See Nike, Inc. v. ADIDAS AG and 812 F. 3d 1326 (Fed. Cir. 2016); Idle Free Sys., Inc. v. Bergstrom, IPR 2012-00027, 2013 WL 5947697, at *4 (PTAB June 11, 2013).

Another potential benefit for patent owners is that members of the examining corps familiar with the art to which the invention relates might more readily evaluate patentability arguments for amendments and provide guidance on patentable claim scope. An amendment examination option also could benefit the PTAB. During an IPR or PGR, a default statutory timeline and motion to amend procedure constrains members of the trial panel from engaging in the type of dialog that occurs between an applicant an examiner to reach agreement on the patentable scope of claims, the trial panel did not have the benefit of conducting a search of the prior art as an examiner could.

Petitioners could share in some of the benefits, as well. If there are many issues and grounds on which a petitioner may oppose a motion to amend, the lone opposition brief contemplated by the PTAB may not provide it an opportunity to note those to the trial panel. An examiner, however, may see or find the same or similar issues when conducting his or her search and examination. Thus, an amendment examination process could potentially provide stakeholders a number of benefits. However, a number of policy and administrative issues lay in the details.


Defining the contours of an examination alternative raises a number of policy and practical administrative issues. Achieving sufficient agreement among stakeholders to promote legislative action raised a call to action for the bar. For some issues, it appears likely consensus approaches could be readily reached. Others might require more effort.


A number of countervailing considerations exist for when a patent owner might begin an examination option. Completing meaningful examination within a 12-month trial period suggests a patent owner may need to present claims earlier in the trial before a motion to amend currently is due. However, advancing amendment to before the patent owner submits its response increases both practical and strategic burdens on the patent owner. Ultimately, the practicalities of timely completing examination may dictate the available timing for submitting proposed amendments.


Which claims may be presented for examination raises a number of issues and, of course, may impact the time needed for examination. One issue is if amendments only to instituted claims may be presented for examination or may a patent owner seek examination for a range of differently-scoped claims. The latter may speed examination in some instances, and lengthen it in others. Some patent owners also might wish to initiate an examination option pre-institution for certain claims. Current practice only allows substitution of amended claims that are part of a trial.


Currently amendments during a PTAB trial "may not enlarge the scope of the claims of the patent," consistent with ex parte reexamination. See 35 U.S.C. § 305. More generally, the statue omits this limit for reissues sought within two years of the patent grant. In the case of an ordinary post-grant review, i.e., one filed within nine months of issuance, normally this will be the case.

Petitioners can raise a number of sound objections to amendments that enlarge the claims in some way during a post-grant trial. When the patent owner would have a broadening reissue option available, in any event, the ultimate substance of the claims alone may not be the paramount policy question. For instance, when the patent is being litigated, filing a separate reissue may impact the speed of proceedings in the courts and patent office, damages, and potentially estoppel arising from the PTAB trial. These concerns, and speculation of the impact they may have for patents involved in parallel litigation, may make consensus difficult for amendments of scope that differs from current practice. Patent owners entitled to pursue claims that were broader in some respect via reissue are likely to pursue that and may request that examination be combined with examination of amendments initiated during trial. What policy the statute and/or Office practice should adopt in this situation will likely require careful balancing among stakeholders.


The Office currently treats the ex parte reexamination of patents as "special," and reissue applications in non-stayed litigation with priority among "special" cases. See 35 U.S.C. § 305; M.P.E.P. § 1442.03. In ordinary prosecution, the Office aims to provide a final disposition within 12 months for prioritized examination under 35 U.S.C. § 111(a) and 37 CFR § 1.102(e)(1) ("Track One") which are given special status. See M.P.E.P. § 708.02(b). Thus, the Office has practices and procedures in place for reexamination and reissue of patent claims within the default timeline of an AIA trial, if given special examination priority. As noted, the available period for examination of a proposed amendment during a trial depends on when the amendments are presented. It appears likely consensus could be reached for amendment examination to be prioritized to complete within the potential timeframe of AIA trials.


An examiner, of course, should have the benefit of the prior art and evidence and other matters related to patentability developed during the trial proceedings. What consideration he or she must or may give to it is a separate question. Given the varied possibilities, a sensible legislative prescription more specific than that the examiner should consider the trial record may be challenging.


Another administrative practicality to address is whether coordination of appeals should be a goal. In particular, should an effort be made within the Office for examination appeals to involve members of the trial panel. Separately, a question to resolve is if a subsequent Federal Circuit appeal should consolidated from both the trial and examination and, if so, the mechanics of implementing that.


More difficult questions arise related to the extent to which the petitioner can attack the validity of amended claims. For patents in litigation, the requirement that an inter partes review be filed within one year of being served with a complaint asserting the patent could, as a practical matter, put amended claims beyond challenge via IPR.

Sound arguments can be made that the original petitioner should have an opportunity to challenge a claim that it could not challenge in its original petition. Sound arguments also exist for the patent owner: Under the current statute, the time limits applicable to filing post-grant challenges have no specific exception for amended claims and it is not readily apparent why the manner by which an amendment came about should alter that.


Another difficult policy question arising from an amendment examination option is deciding what, if any, estoppel should attach to amended claims upon completion of a trial. Petitioners can argue that no estoppel should attach for a claim they could not challenge or raise grounds against its patentability, as amended. This argument may have increased force because the current statute bars arguing a claim "is invalid on any ground that the petitioner raised or reasonably could have raised during" the proceeding. Currently, a petitioner may raise grounds in opposition to a patent owner's motion to amend. If amendments are evaluated solely by the examining corps, the petitioner will not likely have any direct opportunity to raise such grounds. Relatedly, an extension of the current estoppel to grounds the petitioner "reasonably could have raised" may, in this context, be even less justified.

Patent owners can, in turn, argue that there should at least be an estoppel for the scope of the original claims and issues that were raised during the examination. Further, when the patentability of an original challenged claim is upheld during trial, and an amended claim is narrower, allowing a subsequent challenge to the narrower amended claim appears to conflict with the intent of the current statute.


While early efforts to create an amendment examination process were legislative, depending on the contours of the process and its effects, legislative action may not be necessary. As noted above, Congress granted the Director substantial authority to "prescribe regulations . . . setting forth standards and procedures for allowing the patent owner to move to amend the patent." Many of the changes to current practice to implement an amendment examination process may be possible through rulemaking. Whether that is the most desirable approach is a separate question. The Federal Circuit in Aqua Products may conclude that the current PTAB practice for deciding motions to amend wrongly placed a burden on the patent owner without a formal rulemaking, necessitating revisiting the issue in the Patent Office. However, the legislative process may be able to better promote uniformity and predictability through statutory mandate, and is an established vehicle for vetting and balancing stakeholder interests on a number of difficult policy issues. Whether legislative efforts can respond quickly enough to interest from stakeholders remains to be seen, however.

A presumably important balancing Congress made when establishing post-grant challenges in the AIA was that patent owners would be given a chance to amend claims. Patent owners seeking patent rights for their inventions, the public seeking patent quality, and the Office seeking efficient administration of amendment practice should be able to reach consensus on improvements to the amendment process in post grant trials. Providing an examination option for amendments may be a vehicle for that consensus to be reached that is both speedy and just.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
30 Oct 2017, Seminar, California, United States

This program will address some of the hottest legal and policy topics that online platforms have brought to the fore: free speech, hate speech, fake news, privacy and surveillance, artificial intelligence, augmented reality, changing notions of “ownership” of information and software-enabled consumer products, and the perennial issue of copyright.

15 Nov 2017, Other, Dallas, United States

Network and be seen as an information security thought leader. “The Exchange” colloquium is designed for senior business executives and security practitioners fr​om both the public and private sector.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.